- 2.4Impact Factor
- 4.1CiteScore
- 18 daysTime to First Decision
Early Diagnosis and Treatment of Cardiovascular Disease: 2nd Edition
This special issue belongs to the section “Cardiology“.
Special Issue Information
Dear Colleagues,
We are pleased to invite you to contribute to our Special Issue “Early Diagnosis and Treatment of Cardiovascular Disease: 2nd Edition”, which will be published in Medicina.
This Special Issue addresses the continuous development and research of cardiovascular diseases and comorbidities that influence prognosis and treatment, aiming to provide a significant perspective upon early diagnosis and treatment in different conditions. New guidelines on heart failure draw attention to the significant impact of early complete treatment and early diagnosis on cardiac disease. Patients with diabetes mellitus, chronic kidney disease, and anemia must be checked for cardiac conditions, and diagnosis and active treatment should address all risk factors. New data also show the utmost importance of inflammation in cardiac diseases. Moreover, novel biomarkers have emerged to improve diagnosis accuracy. In recent years, evidence has increased regarding the diagnosis and involvement of comorbidities in cardiac function. Furthermore, the recent COVID-19 pandemic showed the importance of thorough follow-up of all data known to influence treatment and prognosis and, of course, the cardiac structures themselves.
This Special Issue aims to offer a complex and current overview of new research related to cardiac disease, expanding our current knowledge and adding important insights related to its management.
Dr. Mihaela-Viviana Ivan
Prof. Dr. Elena Bobescu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- coronary artery disease
- heart failure
- comorbidities
- chronic kidney disease
- anemia
- diabetes mellitus
- arrhythmias
- hypertension
- dyslipidemia
- novel biomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

